SCHEMBL30425697

SCHEMBL30425697

Nc1cc2cc(-c3cn(Cc4ccc(-c5nnc(C(F)F)o5)cc4F)nn3)ccc2cn1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ROCK2 O75116 3/20 0.42
▸ GSK3B P49841 2/20 0.42
▸ PAK4 O96013 1/20 0.42
▸ PIM1 P11309 1/20 0.42
▸ AURKB Q96GD4 1/20 0.42
▸ HDAC6 Q9UBN7 4/20 0.39
▸ HDAC1 Q13547 11/20 0.37
▸ PRKACA P17612 2/20 0.36
▸ RPS6KB1 P23443 2/20 0.36
▸ MAPK1 P28482 2/20 0.36
▸ GSK3A P49840 2/20 0.36
▸ ROCK1 Q13464 2/20 0.36
▸ DYRK1A Q13627 2/20 0.36
▸ AURKA O14965 1/20 0.36
▸ PRKCG P05129 1/20 0.36
▸ CDK1 P06493 1/20 0.36
▸ CDK2 P24941 1/20 0.36
▸ FLT3 P36888 1/20 0.36
▸ PRKAA1 Q13131 1/20 0.36
▸ CDC42BPA Q5VT25 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25388742 1.00 ROCK2 (0.42) ROCK2GSK3BPAK4PIM1AURKB
SCHEMBL25387354 0.91 ROCK2 (0.38) ROCK2GSK3BPAK4PIM1AURKB
SCHEMBL30425608 0.91 ROCK2 (0.38) ROCK2GSK3BPAK4PIM1AURKB
SCHEMBL30425125 0.90 CDC7 (0.44) ROCK2GSK3BPAK4PIM1AURKB
SCHEMBL25221621 0.90 CDC7 (0.44) ROCK2GSK3BPAK4PIM1AURKB
SCHEMBL25388263 0.90 HDAC6 (0.47) ROCK2GSK3BPAK4PIM1AURKB
SCHEMBL30424944 0.90 HDAC6 (0.47) ROCK2GSK3BPAK4PIM1AURKB
SCHEMBL25385035 0.89 HDAC6 (0.38) ROCK2GSK3BPAK4PIM1AURKB
SCHEMBL30425075 0.89 HDAC6 (0.38) ROCK2GSK3BPAK4PIM1AURKB
SCHEMBL25213743 0.88 HDAC6 (0.42) HDAC6HDAC1LRRK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116157398-B Oxadiazole-based selective histone deacetylase 6 inhibitors 意大发马克股份公司 2025-03-11 — — CN claimed
CN-116157398-A 2- (4- ((5- (benzo [ b ] thiophen-3-yl) -1H-tetrazol-1-yl) methyl) phenyl) -5- (difluoromethyl) -1,3, 4-oxadiazole derivatives and similar compounds as selective inhibitors of histone deacetylase 6 (HDAC 6) for the treatment of, for example, peripheral neuropathy 意大发马克股份公司 2023-05-23 — — CN claimed
CN-116157398-B Oxadiazole-based selective histone deacetylase 6 inhibitors 意大发马克股份公司 2025-03-11 — — CN disclosed
CN-116157398-A 2- (4- ((5- (benzo [ b ] thiophen-3-yl) -1H-tetrazol-1-yl) methyl) phenyl) -5- (difluoromethyl) -1,3, 4-oxadiazole derivatives and similar compounds as selective inhibitors of histone deacetylase 6 (HDAC 6) for the treatment of, for example, peripheral neuropathy 意大发马克股份公司 2023-05-23 — — CN disclosed
Send feedback